Nature Protocols, ISSN 1754-2189, 02/2008, Volume 3, Issue 2, pp. 163 - 175
The aim of broth and agar dilution methods is to determine the lowest concentration of the assayed antimicrobial agent (minimal inhibitory concentration, MIC)...
HOST-DEFENSE PEPTIDES | BROAD-SPECTRUM | ETEST | PSEUDOMONAS-AERUGINOSA | SUSCEPTIBILITY | BIOCHEMICAL RESEARCH METHODS | RESISTANCE | TETRACYCLINE | IN-VITRO ACTIVITY | ENTEROBACTERIACEAE | PENICILLIN | Time Factors | Culture Media | Agar | Drug Resistance, Bacterial | Bacteria, Aerobic - drug effects | Anti-Bacterial Agents - pharmacology | Microbial Sensitivity Tests - methods
HOST-DEFENSE PEPTIDES | BROAD-SPECTRUM | ETEST | PSEUDOMONAS-AERUGINOSA | SUSCEPTIBILITY | BIOCHEMICAL RESEARCH METHODS | RESISTANCE | TETRACYCLINE | IN-VITRO ACTIVITY | ENTEROBACTERIACEAE | PENICILLIN | Time Factors | Culture Media | Agar | Drug Resistance, Bacterial | Bacteria, Aerobic - drug effects | Anti-Bacterial Agents - pharmacology | Microbial Sensitivity Tests - methods
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2010, Volume 54, Issue 8, pp. 3372 - 3382
As multidrug resistance increases alarmingly, polymyxin B and colistin are increasingly being used in the clinic to treat serious Pseudomonas aeruginosa...
LIPID-A | SALMONELLA-TYPHIMURIUM | PMRA-PMRB | PHOP-PHOQ | LIPOPOLYSACCHARIDE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | CATIONIC ANTIMICROBIAL PEPTIDES | CYSTIC-FIBROSIS AIRWAY | SENSOR KINASE | EXPRESSION | BIOFILM FORMATION | Adaptation, Physiological | Polymyxin B - pharmacology | Signal Transduction | Humans | Bacterial Proteins - genetics | Repressor Proteins - genetics | Pseudomonas aeruginosa - drug effects | Microbial Sensitivity Tests | Colistin - pharmacology | Pseudomonas aeruginosa - genetics | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | Mutation | Drug Resistance, Bacterial - genetics | Gene Expression Regulation, Bacterial | Repressor Proteins - metabolism
LIPID-A | SALMONELLA-TYPHIMURIUM | PMRA-PMRB | PHOP-PHOQ | LIPOPOLYSACCHARIDE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | CATIONIC ANTIMICROBIAL PEPTIDES | CYSTIC-FIBROSIS AIRWAY | SENSOR KINASE | EXPRESSION | BIOFILM FORMATION | Adaptation, Physiological | Polymyxin B - pharmacology | Signal Transduction | Humans | Bacterial Proteins - genetics | Repressor Proteins - genetics | Pseudomonas aeruginosa - drug effects | Microbial Sensitivity Tests | Colistin - pharmacology | Pseudomonas aeruginosa - genetics | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | Mutation | Drug Resistance, Bacterial - genetics | Gene Expression Regulation, Bacterial | Repressor Proteins - metabolism
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2012, Volume 56, Issue 12, pp. 6212 - 6222
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
CELL ENVELOPES | DESIGN | CHEMICAL ALTERATIONS | PMRA-PMRB | PHOP-PHOQ | CLASSIFICATION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | ANTIMICROBIAL PEPTIDES | EXPRESSION | POLYMYXIN-B | REGULATORY SYSTEM | Polymyxin B - pharmacology | Protein Kinases - genetics | Pseudomonas aeruginosa - growth & development | Peptides - genetics | Molecular Sequence Data | Pseudomonas aeruginosa - physiology | Genetic Complementation Test | Microbial Sensitivity Tests | Cations - pharmacology | Microarray Analysis | Anti-Bacterial Agents - chemistry | Computer Simulation | DNA Transposable Elements - genetics | Plasmids - genetics | Drug Resistance, Bacterial - genetics | Amino Acid Sequence | Cations - chemistry | Peptides - physiology | Bacterial Proteins - genetics | Bacterial Proteins - physiology | Operon - genetics | Pseudomonas aeruginosa - genetics | Protein Kinases - physiology | Drug Resistance, Bacterial - physiology | Anti-Bacterial Agents - pharmacology | Mechanisms of Resistance
CELL ENVELOPES | DESIGN | CHEMICAL ALTERATIONS | PMRA-PMRB | PHOP-PHOQ | CLASSIFICATION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | ANTIMICROBIAL PEPTIDES | EXPRESSION | POLYMYXIN-B | REGULATORY SYSTEM | Polymyxin B - pharmacology | Protein Kinases - genetics | Pseudomonas aeruginosa - growth & development | Peptides - genetics | Molecular Sequence Data | Pseudomonas aeruginosa - physiology | Genetic Complementation Test | Microbial Sensitivity Tests | Cations - pharmacology | Microarray Analysis | Anti-Bacterial Agents - chemistry | Computer Simulation | DNA Transposable Elements - genetics | Plasmids - genetics | Drug Resistance, Bacterial - genetics | Amino Acid Sequence | Cations - chemistry | Peptides - physiology | Bacterial Proteins - genetics | Bacterial Proteins - physiology | Operon - genetics | Pseudomonas aeruginosa - genetics | Protein Kinases - physiology | Drug Resistance, Bacterial - physiology | Anti-Bacterial Agents - pharmacology | Mechanisms of Resistance
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2010, Volume 54, Issue 10, pp. 4159 - 4167
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
RESISTANCE MECHANISMS | CELL-DIVISION | AMPC | CYSTIC-FIBROSIS PATIENTS | MUTANT LIBRARY | ESCHERICHIA-COLI | BIOCHEMICAL-CHARACTERIZATION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MEXAB-OPRM | EXPRESSION | MEXCD-OPRJ | Microbial Sensitivity Tests | Phenotype | beta-Lactams - pharmacology | beta-Lactamases - genetics | Pseudomonas aeruginosa - genetics | Bacterial Proteins - genetics | Serine Endopeptidases - genetics | Mutation | Pseudomonas aeruginosa - drug effects | Sigma Factor - genetics | Genetic Complementation Test | Mechanisms of Resistance
RESISTANCE MECHANISMS | CELL-DIVISION | AMPC | CYSTIC-FIBROSIS PATIENTS | MUTANT LIBRARY | ESCHERICHIA-COLI | BIOCHEMICAL-CHARACTERIZATION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MEXAB-OPRM | EXPRESSION | MEXCD-OPRJ | Microbial Sensitivity Tests | Phenotype | beta-Lactams - pharmacology | beta-Lactamases - genetics | Pseudomonas aeruginosa - genetics | Bacterial Proteins - genetics | Serine Endopeptidases - genetics | Mutation | Pseudomonas aeruginosa - drug effects | Sigma Factor - genetics | Genetic Complementation Test | Mechanisms of Resistance
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2013, Volume 57, Issue 1, pp. 110 - 119
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
POLYACRYLAMIDE-GELS | 2-COMPONENT REGULATORY SYSTEM | OUTER-MEMBRANE | GENETIC-DETERMINANTS | CYSTIC-FIBROSIS PATIENTS | IN-VIVO | PMRA-PMRB | PHOP-PHOQ | RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | CORE OLIGOSACCHARIDE | Polymyxin B - pharmacology | Genes, Bacterial | Gene Library | Transcriptome | Pseudomonas aeruginosa - drug effects | DNA Transposable Elements | Lipopolysaccharides - genetics | Cell Membrane - chemistry | Pseudomonas aeruginosa - genetics | Cell Membrane Permeability - drug effects | Anti-Bacterial Agents - pharmacology | Cell Membrane - metabolism | Lipopolysaccharides - chemistry | Mutation | Drug Resistance, Bacterial - genetics | Cell Membrane - drug effects | Mechanisms of Resistance
POLYACRYLAMIDE-GELS | 2-COMPONENT REGULATORY SYSTEM | OUTER-MEMBRANE | GENETIC-DETERMINANTS | CYSTIC-FIBROSIS PATIENTS | IN-VIVO | PMRA-PMRB | PHOP-PHOQ | RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | CORE OLIGOSACCHARIDE | Polymyxin B - pharmacology | Genes, Bacterial | Gene Library | Transcriptome | Pseudomonas aeruginosa - drug effects | DNA Transposable Elements | Lipopolysaccharides - genetics | Cell Membrane - chemistry | Pseudomonas aeruginosa - genetics | Cell Membrane Permeability - drug effects | Anti-Bacterial Agents - pharmacology | Cell Membrane - metabolism | Lipopolysaccharides - chemistry | Mutation | Drug Resistance, Bacterial - genetics | Cell Membrane - drug effects | Mechanisms of Resistance
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 04/2007, Volume 45, Issue 4, pp. 1167 - 1174
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
STRAINS | ETEST ESBL | TESTS | CEFEPIME | ESCHERICHIA-COLI | CONFIRMATION PANEL | KLEBSIELLA | RESISTANCE | MICROBIOLOGY | BD PHOENIX | PREVALENCE | Morganella morganii - enzymology | Predictive Value of Tests | Enterobacteriaceae - enzymology | beta-Lactam Resistance | Serratia marcescens - drug effects | Escherichia coli - drug effects | Enterobacter - enzymology | beta-Lactamases - biosynthesis | Morganella morganii - genetics | Morganella morganii - drug effects | Citrobacter freundii - drug effects | beta-Lactamases - genetics | beta-Lactamases - analysis | Sensitivity and Specificity | Serratia marcescens - enzymology | Citrobacter freundii - genetics | Proteus - genetics | Enterobacter - genetics | Escherichia coli - enzymology | Klebsiella - genetics | Enterobacteriaceae - genetics | Klebsiella - enzymology | Proteus - drug effects | Proteus - enzymology | Serratia marcescens - genetics | Klebsiella - drug effects | Escherichia coli - genetics | Enterobacteriaceae - drug effects | Citrobacter freundii - enzymology | Enterobacter - drug effects | Microbial Sensitivity Tests - methods | Bacteriology
STRAINS | ETEST ESBL | TESTS | CEFEPIME | ESCHERICHIA-COLI | CONFIRMATION PANEL | KLEBSIELLA | RESISTANCE | MICROBIOLOGY | BD PHOENIX | PREVALENCE | Morganella morganii - enzymology | Predictive Value of Tests | Enterobacteriaceae - enzymology | beta-Lactam Resistance | Serratia marcescens - drug effects | Escherichia coli - drug effects | Enterobacter - enzymology | beta-Lactamases - biosynthesis | Morganella morganii - genetics | Morganella morganii - drug effects | Citrobacter freundii - drug effects | beta-Lactamases - genetics | beta-Lactamases - analysis | Sensitivity and Specificity | Serratia marcescens - enzymology | Citrobacter freundii - genetics | Proteus - genetics | Enterobacter - genetics | Escherichia coli - enzymology | Klebsiella - genetics | Enterobacteriaceae - genetics | Klebsiella - enzymology | Proteus - drug effects | Proteus - enzymology | Serratia marcescens - genetics | Klebsiella - drug effects | Escherichia coli - genetics | Enterobacteriaceae - drug effects | Citrobacter freundii - enzymology | Enterobacter - drug effects | Microbial Sensitivity Tests - methods | Bacteriology
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2008, Volume 52, Issue 12, pp. 4486 - 4491
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MECHANISMS | CYSTIC-FIBROSIS | GYRASE | Microbial Sensitivity Tests | Gene Library | Pseudomonas aeruginosa - genetics | Fluoroquinolones - pharmacology | Humans | Bacterial Proteins - genetics | Ciprofloxacin - pharmacology | Drug Resistance, Bacterial | Anti-Bacterial Agents - pharmacology | Mutation | Pseudomonas aeruginosa - drug effects | Mechanisms of Resistance
RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MECHANISMS | CYSTIC-FIBROSIS | GYRASE | Microbial Sensitivity Tests | Gene Library | Pseudomonas aeruginosa - genetics | Fluoroquinolones - pharmacology | Humans | Bacterial Proteins - genetics | Ciprofloxacin - pharmacology | Drug Resistance, Bacterial | Anti-Bacterial Agents - pharmacology | Mutation | Pseudomonas aeruginosa - drug effects | Mechanisms of Resistance
Journal Article
Journal of Bacteriology, ISSN 0021-9193, 08/2008, Volume 190, Issue 16, pp. 5624 - 5634
Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
Biofilms - drug effects | Oligonucleotide Array Sequence Analysis | Antimicrobial Cationic Peptides - pharmacology | Drug Resistance, Bacterial | Transcription Factors - biosynthesis | Gene Expression Profiling | Pseudomonas aeruginosa - physiology | Microbial Viability | Permeability | Pseudomonas aeruginosa - drug effects | Genetic Complementation Test | Bacterial Adhesion | Polymyxins - pharmacology | Gene Deletion | Anti-Bacterial Agents - pharmacology | Bacterial Proteins - biosynthesis | Mutagenesis, Insertional | DNA-Binding Proteins - biosynthesis | Locomotion - drug effects | Physiological aspects | Pseudomonas aeruginosa | Anti-infective agents | Genetic aspects | Research | Peptides | Index Medicus | Gene Regulation
Biofilms - drug effects | Oligonucleotide Array Sequence Analysis | Antimicrobial Cationic Peptides - pharmacology | Drug Resistance, Bacterial | Transcription Factors - biosynthesis | Gene Expression Profiling | Pseudomonas aeruginosa - physiology | Microbial Viability | Permeability | Pseudomonas aeruginosa - drug effects | Genetic Complementation Test | Bacterial Adhesion | Polymyxins - pharmacology | Gene Deletion | Anti-Bacterial Agents - pharmacology | Bacterial Proteins - biosynthesis | Mutagenesis, Insertional | DNA-Binding Proteins - biosynthesis | Locomotion - drug effects | Physiological aspects | Pseudomonas aeruginosa | Anti-infective agents | Genetic aspects | Research | Peptides | Index Medicus | Gene Regulation
Journal Article
Journal of Bacteriology, ISSN 0021-9193, 09/2009, Volume 191, Issue 18, pp. 5592 - 5602
Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
METHIONINE SYNTHESIS | VIRULENCE FACTORS | QUORUM | GLYA GENE | FLAGELLAR | ESCHERICHIA-COLI | GENE-EXPRESSION | MICROBIOLOGY | RHAMNOLIPID SYNTHESIS | BIOFILM FORMATION | MOTILITY | Oligonucleotide Array Sequence Analysis | Signal Transduction | Bacterial Proteins - genetics | Gene Expression Profiling | Pseudomonas aeruginosa - physiology | DNA Transposable Elements | DNA, Bacterial - genetics | ATP-Binding Cassette Transporters - genetics | Pseudomonas aeruginosa - genetics | Pseudomonas aeruginosa - metabolism | Trans-Activators - genetics | ATP-Binding Cassette Transporters - metabolism | Bacterial Proteins - metabolism | Trans-Activators - metabolism | Mutagenesis, Insertional | Mutation | Gene Expression Regulation, Bacterial | Physiological aspects | Pseudomonas aeruginosa | Genetic transcription | Research | Bacterial genetics | Index Medicus | Physiology and Metabolism
METHIONINE SYNTHESIS | VIRULENCE FACTORS | QUORUM | GLYA GENE | FLAGELLAR | ESCHERICHIA-COLI | GENE-EXPRESSION | MICROBIOLOGY | RHAMNOLIPID SYNTHESIS | BIOFILM FORMATION | MOTILITY | Oligonucleotide Array Sequence Analysis | Signal Transduction | Bacterial Proteins - genetics | Gene Expression Profiling | Pseudomonas aeruginosa - physiology | DNA Transposable Elements | DNA, Bacterial - genetics | ATP-Binding Cassette Transporters - genetics | Pseudomonas aeruginosa - genetics | Pseudomonas aeruginosa - metabolism | Trans-Activators - genetics | ATP-Binding Cassette Transporters - metabolism | Bacterial Proteins - metabolism | Trans-Activators - metabolism | Mutagenesis, Insertional | Mutation | Gene Expression Regulation, Bacterial | Physiological aspects | Pseudomonas aeruginosa | Genetic transcription | Research | Bacterial genetics | Index Medicus | Physiology and Metabolism
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2008, Volume 52, Issue 12, pp. 4213 - 4219
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
CELLS | TRANSPORT | BAND LIPOPOLYSACCHARIDE | A-BAND | MUTANT LIBRARY | MEMBRANE | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | CYSTIC-FIBROSIS | GENTAMICIN | STREPTOMYCIN | Genes, Bacterial | Gene Library | Humans | Pseudomonas aeruginosa - growth & development | Tobramycin - pharmacology | Bacterial Proteins - genetics | Pseudomonas aeruginosa - drug effects | DNA Transposable Elements | Microbial Sensitivity Tests | Pseudomonas aeruginosa - genetics | Culture Media | Anti-Bacterial Agents - pharmacology | Mutation | Aminoglycosides - pharmacology | Drug Resistance, Bacterial - genetics | Mechanisms of Resistance
CELLS | TRANSPORT | BAND LIPOPOLYSACCHARIDE | A-BAND | MUTANT LIBRARY | MEMBRANE | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | CYSTIC-FIBROSIS | GENTAMICIN | STREPTOMYCIN | Genes, Bacterial | Gene Library | Humans | Pseudomonas aeruginosa - growth & development | Tobramycin - pharmacology | Bacterial Proteins - genetics | Pseudomonas aeruginosa - drug effects | DNA Transposable Elements | Microbial Sensitivity Tests | Pseudomonas aeruginosa - genetics | Culture Media | Anti-Bacterial Agents - pharmacology | Mutation | Aminoglycosides - pharmacology | Drug Resistance, Bacterial - genetics | Mechanisms of Resistance
Journal Article
Virulence, ISSN 2150-5594, 03/2011, Volume 2, Issue 2, pp. 144 - 146
Pseudomonas aeruginosa is a relevant opportunistic pathogen particularly problematic due to its low intrinsic susceptibility to antibiotics. Intrinsic...
Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | Pseudomonas aeruginosa | Intrinsic resistance | Resistome | β-lactam resistance | β-lactamase | BACTERIA | INFECTIONS | ESCHERICHIA-COLI | SUSCEPTIBILITY | ANTIBIOTIC-RESISTANCE | resistome | MICROBIOLOGY | MECHANISMS | IMMUNOLOGY | EFFLUX | GENETIC-DETERMINANTS | ADAPTATION | beta-lactamase | beta-lactam resistance | HYPERMUTATION | Genes, Bacterial | beta-Lactam Resistance | beta-Lactams - pharmacology | DNA, Bacterial - genetics | Pseudomonas aeruginosa - genetics | Humans | Anti-Bacterial Agents - pharmacology | Mutagenesis, Insertional | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | DNA Transposable Elements
Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | Pseudomonas aeruginosa | Intrinsic resistance | Resistome | β-lactam resistance | β-lactamase | BACTERIA | INFECTIONS | ESCHERICHIA-COLI | SUSCEPTIBILITY | ANTIBIOTIC-RESISTANCE | resistome | MICROBIOLOGY | MECHANISMS | IMMUNOLOGY | EFFLUX | GENETIC-DETERMINANTS | ADAPTATION | beta-lactamase | beta-lactam resistance | HYPERMUTATION | Genes, Bacterial | beta-Lactam Resistance | beta-Lactams - pharmacology | DNA, Bacterial - genetics | Pseudomonas aeruginosa - genetics | Humans | Anti-Bacterial Agents - pharmacology | Mutagenesis, Insertional | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | DNA Transposable Elements
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 03/2018, Volume 18, Issue 3, pp. e99 - e106
Antimicrobial resistance poses a growing threat to public health and the provision of health care. Its surveillance should provide up-to-date and relevant...
INFECTIOUS DISEASES | Animals | Humans | Bacteria - drug effects | Bacterial Infections - epidemiology | Drug Resistance, Bacterial | Europe - epidemiology | Anti-Bacterial Agents - pharmacology | Population Surveillance | Bacterial Infections - microbiology | Health care | Regulators | Target recognition | Warning systems | Disease | Laboratories | Systematic review | Drug resistance | Veterinary medicine | Antiinfectives and antibacterials | Epidemiology | Management reports | Clinical outcomes | Microorganisms | E coli | Food chains | Information sharing | Nosocomial infections | Pharmaceutical industry | Strains (organisms) | Public health | Typing | Health risks | Antimicrobial agents | Early warning systems | Disease prevention | Regeneration | Surveillance systems | Hospitals | Surveillance | Antibiotics | Collaboration | Data collection | Food safety | Antimicrobial resistance | Drug discovery
INFECTIOUS DISEASES | Animals | Humans | Bacteria - drug effects | Bacterial Infections - epidemiology | Drug Resistance, Bacterial | Europe - epidemiology | Anti-Bacterial Agents - pharmacology | Population Surveillance | Bacterial Infections - microbiology | Health care | Regulators | Target recognition | Warning systems | Disease | Laboratories | Systematic review | Drug resistance | Veterinary medicine | Antiinfectives and antibacterials | Epidemiology | Management reports | Clinical outcomes | Microorganisms | E coli | Food chains | Information sharing | Nosocomial infections | Pharmaceutical industry | Strains (organisms) | Public health | Typing | Health risks | Antimicrobial agents | Early warning systems | Disease prevention | Regeneration | Surveillance systems | Hospitals | Surveillance | Antibiotics | Collaboration | Data collection | Food safety | Antimicrobial resistance | Drug discovery
Journal Article
BMJ Open, ISSN 2044-6055, 04/2018, Volume 8, Issue 4, p. e020251
ObjectiveComplicated urinary tract infections (cUTIs) impose a high burden on healthcare systems and are a frequent cause of hospitalisation. The aims of this...
cost of illness | urinary tract infections | health economics | MEDICINE, GENERAL & INTERNAL | IMPACT | MANAGEMENT | MORBIDITY | ERA | PATTERNS | CARE | EPIDEMIOLOGY | Prevalence | Humans | Middle Aged | Male | Urinary Tract Infections - economics | Gram-Negative Bacteria - isolation & purification | Magnets | Greece | Drug Resistance, Multiple, Bacterial | Aged, 80 and over | Female | Urinary Tract Infections - microbiology | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Bulgaria | Anti-Bacterial Agents - economics | Romania | Hungary | Spain | Gram-Negative Bacterial Infections - economics | Health Care Costs | Turkey | Italy | Aged | Israel | Hospitalization - economics | Disease | Antimicrobial agents | Drug resistance | Epidemiology | Cost control | Urinary tract diseases | Studies | Hospitals | E coli | Cost estimates | Urinary tract infections | Bacteria | Gram-negative bacteria | Urogenital system
cost of illness | urinary tract infections | health economics | MEDICINE, GENERAL & INTERNAL | IMPACT | MANAGEMENT | MORBIDITY | ERA | PATTERNS | CARE | EPIDEMIOLOGY | Prevalence | Humans | Middle Aged | Male | Urinary Tract Infections - economics | Gram-Negative Bacteria - isolation & purification | Magnets | Greece | Drug Resistance, Multiple, Bacterial | Aged, 80 and over | Female | Urinary Tract Infections - microbiology | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Bulgaria | Anti-Bacterial Agents - economics | Romania | Hungary | Spain | Gram-Negative Bacterial Infections - economics | Health Care Costs | Turkey | Italy | Aged | Israel | Hospitalization - economics | Disease | Antimicrobial agents | Drug resistance | Epidemiology | Cost control | Urinary tract diseases | Studies | Hospitals | E coli | Cost estimates | Urinary tract infections | Bacteria | Gram-negative bacteria | Urogenital system
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2007, Volume 51, Issue 10, pp. 3642 - 3649
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
BETA-LACTAM RESISTANCE | INVITRO MODEL | ANTIBACTERIAL ACTIVITY | INTERMITTENT INFUSION | EFFLUX PUMPS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MECHANISMS | CYSTIC-FIBROSIS | ANTIMICROBIAL RESISTANCE | LUNG INFECTIONS | AMPD | Porins - genetics | Ceftazidime - pharmacology | Humans | Middle Aged | Enzyme Inhibitors - pharmacology | Thienamycins - pharmacokinetics | Genotype | Male | Colony Count, Microbial | Pseudomonas aeruginosa - drug effects | Thienamycins - pharmacology | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Ceftazidime - pharmacokinetics | Microbial Sensitivity Tests | Phenotype | DNA, Bacterial - genetics | Pseudomonas aeruginosa - genetics | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | beta-Lactamase Inhibitors | Drug Resistance, Bacterial - genetics | Drug Resistance, Multiple, Bacterial - genetics | Experimental Therapeutics
BETA-LACTAM RESISTANCE | INVITRO MODEL | ANTIBACTERIAL ACTIVITY | INTERMITTENT INFUSION | EFFLUX PUMPS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MECHANISMS | CYSTIC-FIBROSIS | ANTIMICROBIAL RESISTANCE | LUNG INFECTIONS | AMPD | Porins - genetics | Ceftazidime - pharmacology | Humans | Middle Aged | Enzyme Inhibitors - pharmacology | Thienamycins - pharmacokinetics | Genotype | Male | Colony Count, Microbial | Pseudomonas aeruginosa - drug effects | Thienamycins - pharmacology | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Ceftazidime - pharmacokinetics | Microbial Sensitivity Tests | Phenotype | DNA, Bacterial - genetics | Pseudomonas aeruginosa - genetics | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | beta-Lactamase Inhibitors | Drug Resistance, Bacterial - genetics | Drug Resistance, Multiple, Bacterial - genetics | Experimental Therapeutics
Journal Article
BMJ Open, ISSN 2044-6055, 07/2016, Volume 6, Issue 7, p. e011500
IntroductionThe emergence of multidrug resistant (MDR) Gram-negative bacteria (GNB), including carbapenemase-producing strains, has become a major therapeutic...
MEDICINE, GENERAL & INTERNAL | MORBIDITY | SMART | EPIDEMIOLOGY | ESCHERICHIA-COLI | Prevalence | Outcome Assessment (Health Care) | Humans | Middle Aged | Risk Factors | Clinical Protocols | Gram-Negative Bacterial Infections - drug therapy | Male | Urinary Tract Infections - drug therapy | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Urinary Tract Infections - epidemiology | Gram-Negative Bacterial Infections - epidemiology | Female | Aged | Retrospective Studies | Drug Resistance, Multiple, Bacterial - drug effects | Drug side effects | Ús terapèutic | Resistència als medicaments | Urinary tract infections | Efectes secundaris dels medicaments | Gram-negative bacteria | Medicaments antibacterians | Drug resistance | Bacteris gramnegatius | Antibacterial agents | Therapeutic use | Infeccions del tracte urinari
MEDICINE, GENERAL & INTERNAL | MORBIDITY | SMART | EPIDEMIOLOGY | ESCHERICHIA-COLI | Prevalence | Outcome Assessment (Health Care) | Humans | Middle Aged | Risk Factors | Clinical Protocols | Gram-Negative Bacterial Infections - drug therapy | Male | Urinary Tract Infections - drug therapy | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Urinary Tract Infections - epidemiology | Gram-Negative Bacterial Infections - epidemiology | Female | Aged | Retrospective Studies | Drug Resistance, Multiple, Bacterial - drug effects | Drug side effects | Ús terapèutic | Resistència als medicaments | Urinary tract infections | Efectes secundaris dels medicaments | Gram-negative bacteria | Medicaments antibacterians | Drug resistance | Bacteris gramnegatius | Antibacterial agents | Therapeutic use | Infeccions del tracte urinari
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 01/2019, Volume 68, Issue 1, pp. 29 - 36
In patients with complicated urinary tract infections, we found no benefit of early appropriate empirical treatment on survival rates or other outcomes....
pyelonephritis | risk factors | treatment failure | complicated urinary tract infection | bacterial resistance | INFECTIOUS DISEASES | EMPIRICAL ANTIBIOTIC-TREATMENT | ESCHERICHIA-COLI | ADULTS | MICROBIOLOGY | IMMUNOLOGY | ACUTE PYELONEPHRITIS | IMPACT | THERAPY | BACTEREMIA | OUTCOMES | EPIDEMIOLOGY
pyelonephritis | risk factors | treatment failure | complicated urinary tract infection | bacterial resistance | INFECTIOUS DISEASES | EMPIRICAL ANTIBIOTIC-TREATMENT | ESCHERICHIA-COLI | ADULTS | MICROBIOLOGY | IMMUNOLOGY | ACUTE PYELONEPHRITIS | IMPACT | THERAPY | BACTEREMIA | OUTCOMES | EPIDEMIOLOGY
Journal Article
17.
Full Text
Mutator Genes Giving Rise to Decreased Antibiotic Susceptibility in Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2008, Volume 52, Issue 10, pp. 3810 - 3813
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
SYSTEM | REPAIR | MUTL | MUTANT LIBRARY | ESCHERICHIA-COLI | PREVENTION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | CYSTIC-FIBROSIS | HYPERMUTATION | Genes, Bacterial | Pseudomonas aeruginosa - isolation & purification | Cystic Fibrosis - microbiology | Pseudomonas Infections - drug therapy | Humans | Ciprofloxacin - pharmacology | Genomic Library | Pseudomonas Infections - complications | DNA Repair - genetics | Pseudomonas aeruginosa - drug effects | Cystic Fibrosis - complications | Pseudomonas Infections - microbiology | Phenotype | DNA, Bacterial - genetics | Pseudomonas aeruginosa - genetics | DNA Transposable Elements - genetics | Anti-Bacterial Agents - pharmacology | Mutation | Drug Resistance, Multiple, Bacterial - genetics | Cystic Fibrosis - drug therapy | Mechanisms of Resistance
SYSTEM | REPAIR | MUTL | MUTANT LIBRARY | ESCHERICHIA-COLI | PREVENTION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | CYSTIC-FIBROSIS | HYPERMUTATION | Genes, Bacterial | Pseudomonas aeruginosa - isolation & purification | Cystic Fibrosis - microbiology | Pseudomonas Infections - drug therapy | Humans | Ciprofloxacin - pharmacology | Genomic Library | Pseudomonas Infections - complications | DNA Repair - genetics | Pseudomonas aeruginosa - drug effects | Cystic Fibrosis - complications | Pseudomonas Infections - microbiology | Phenotype | DNA, Bacterial - genetics | Pseudomonas aeruginosa - genetics | DNA Transposable Elements - genetics | Anti-Bacterial Agents - pharmacology | Mutation | Drug Resistance, Multiple, Bacterial - genetics | Cystic Fibrosis - drug therapy | Mechanisms of Resistance
Journal Article